BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marckmann P, Skov L, Rossen K, Dupont A, Damholt MB, Heaf JG, Thomsen HS. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol. 2006;17:2359-2362. [PMID: 16885403 DOI: 10.1681/asn.2006060601] [Cited by in Crossref: 988] [Cited by in F6Publishing: 231] [Article Influence: 65.9] [Reference Citation Analysis]
Number Citing Articles
1 Steen H, Madadi-Schroeder M, Lehrke S, Lossnitzer D, Giannitsis E, Katus HA. Staged cardiovascular magnetic resonance for differential diagnosis of troponin T positive patients with low likelihood for acute coronary syndrome. J Cardiovasc Magn Reson 2010;12:51. [PMID: 20840783 DOI: 10.1186/1532-429X-12-51] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
2 Bennett CL, Qureshi ZP, Sartor AO, Norris LB, Murday A, Xirasagar S, Thomsen HS. Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease. Clin Kidney J 2012;5:82-8. [PMID: 22833806 DOI: 10.1093/ckj/sfr172] [Cited by in Crossref: 64] [Cited by in F6Publishing: 53] [Article Influence: 7.1] [Reference Citation Analysis]
3 Xia L, Zhang C, Li M, Wang K, Wang Y, Xu P, Hu Y. Nitroxide-radicals-modified gold nanorods for in vivo CT/MRI-guided photothermal cancer therapy. Int J Nanomedicine 2018;13:7123-34. [PMID: 30464463 DOI: 10.2147/IJN.S171804] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
4 Gupta A, Caravan P, Price WS, Platas-Iglesias C, Gale EM. Applications for Transition-Metal Chemistry in Contrast-Enhanced Magnetic Resonance Imaging. Inorg Chem 2020;59:6648-78. [PMID: 32367714 DOI: 10.1021/acs.inorgchem.0c00510] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 19.0] [Reference Citation Analysis]
5 Morcos SK, Haylor J. Pathophysiology of nephrogenic systemic fibrosis: A review of experimental data. World J Radiol. 2010;2:427-433. [PMID: 21179310 DOI: 10.4329/wjr.v2.i11.427] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
6 Alwasiyah D, Murphy C, Jannetto P, Hogg M, Beuhler MC. Urinary Gadolinium Levels After Contrast-Enhanced MRI in Individuals with Normal Renal Function: a Pilot Study. J Med Toxicol 2019;15:121-7. [PMID: 30543028 DOI: 10.1007/s13181-018-0693-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
7 Gharagouzloo CA, McMahon PN, Sridhar S. Quantitative contrast-enhanced MRI with superparamagnetic nanoparticles using ultrashort time-to-echo pulse sequences. Magn Reson Med 2015;74:431-41. [PMID: 25168606 DOI: 10.1002/mrm.25426] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
8 Tian X, Yang F, Yang C, Peng Y, Chen D, Zhu J, He F, Li L, Chen X. Toxicity evaluation of Gd2O3@SiO2 nanoparticles prepared by laser ablation in liquid as MRI contrast agents in vivo. Int J Nanomedicine 2014;9:4043-53. [PMID: 25187708 DOI: 10.2147/IJN.S66164] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
9 Xie Y, Fan Z, Saouaf R, Natsuaki Y, Laub G, Li D. Adaptive online self-gating (ADIOS) for free-breathing noncontrast renal MR angiography. Magn Reson Med 2015;73:312-7. [PMID: 24478221 DOI: 10.1002/mrm.25121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
10 Colafati GS, Rossi E, Carducci C, Piga S, Voicu IP, Mastronuzzi A, Tomà P. Half-dose versus full-dose macrocyclic gadolinium at 3-T magnetic resonance imaging in paediatric bone and soft-tissue disease. Pediatr Radiol 2018;48:1724-35. [PMID: 30046901 DOI: 10.1007/s00247-018-4204-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Yoshioka K, Tanaka R. MRI and MRA of Aortic Disease. Ann Vasc Dis 2010;3:196-201. [PMID: 23555410 DOI: 10.3400/avd.sasdi10003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
12 Wentland AL, Sadowski EA, Djamali A, Grist TM, Becker BN, Fain SB. Quantitative MR measures of intrarenal perfusion in the assessment of transplanted kidneys: initial experience. Acad Radiol. 2009;16:1077-1085. [PMID: 19539502 DOI: 10.1016/j.acra.2009.03.020] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
13 Wu WC, Chen YF, Tseng HM, Yang SC, My PC. Caveat of measuring perfusion indexes using intravoxel incoherent motion magnetic resonance imaging in the human brain. Eur Radiol 2015;25:2485-92. [PMID: 25693668 DOI: 10.1007/s00330-015-3655-x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 8.0] [Reference Citation Analysis]
14 Maravilla KR, San-Juan D, Kim SJ, Elizondo-Riojas G, Fink JR, Escobar W, Bag A, Roberts DR, Hao J, Pitrou C, Tsiouris AJ, Herskovits E, Fiebach JB. Comparison of Gadoterate Meglumine and Gadobutrol in the MRI Diagnosis of Primary Brain Tumors: A Double-Blind Randomized Controlled Intraindividual Crossover Study (the REMIND Study). AJNR Am J Neuroradiol 2017;38:1681-8. [PMID: 28663267 DOI: 10.3174/ajnr.A5316] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
15 Alarifi S, Ali H, Alkahtani S, Alessia MS. Regulation of apoptosis through bcl-2/bax proteins expression and DNA damage by nano-sized gadolinium oxide. Int J Nanomedicine 2017;12:4541-51. [PMID: 28684914 DOI: 10.2147/IJN.S139326] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
16 Vidyasagar R, Abernethy L, Pizer B, Avula S, Parkes LM. Quantitative measurement of blood flow in paediatric brain tumours-a comparative study of dynamic susceptibility contrast and multi time-point arterial spin labelled MRI. Br J Radiol 2016;89:20150624. [PMID: 26975495 DOI: 10.1259/bjr.20150624] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
17 Thoenen J, Stevens KJ, Turmezei TD, Chaudhari A, Watkins LE, McWalter EJ, Hargreaves BA, Gold GE, MacKay JW, Kogan F. Non-contrast MRI of synovitis in the knee using quantitative DESS. Eur Radiol 2021. [PMID: 33993332 DOI: 10.1007/s00330-021-08025-2] [Reference Citation Analysis]
18 Shen ZT, Zheng S, Gounis MJ, Sigalov AB. Diagnostic Magnetic Resonance Imaging of Atherosclerosis in Apolipoprotein E Knockout Mouse Model Using Macrophage-Targeted Gadolinium-Containing Synthetic Lipopeptide Nanoparticles. PLoS One 2015;10:e0143453. [PMID: 26569115 DOI: 10.1371/journal.pone.0143453] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
19 Osterode W, Falkenberg G, Regele H. Gadolinium distribution in kidney tissue determined and quantified by micro synchrotron X-ray fluorescence. Biometals 2021;34:341-50. [PMID: 33486677 DOI: 10.1007/s10534-020-00284-8] [Reference Citation Analysis]
20 Bae JS, Lee JM, Jeon SK, Jang S. Comparison of MicroFlow Imaging with color and power Doppler imaging for detecting and characterizing blood flow signals in hepatocellular carcinoma.Ultrasonography. 2020;39:85-93. [PMID: 31759383 DOI: 10.14366/usg.19033] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
21 McMahon MT, Bulte JWM. Two decades of dendrimers as versatile MRI agents: a tale with and without metals. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2018;10:e1496. [PMID: 28895298 DOI: 10.1002/wnan.1496] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
22 Kundu S. Central venous obstruction management. Semin Intervent Radiol 2009;26:115-21. [PMID: 21326501 DOI: 10.1055/s-0029-1222454] [Cited by in Crossref: 36] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
23 Addisu KD, Hailemeskel BZ, Mekuria SL, Andrgie AT, Lin YC, Tsai HC. Bioinspired, Manganese-Chelated Alginate-Polydopamine Nanomaterials for Efficient in Vivo T1-Weighted Magnetic Resonance Imaging. ACS Appl Mater Interfaces 2018;10:5147-60. [PMID: 29277987 DOI: 10.1021/acsami.7b13396] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 9.7] [Reference Citation Analysis]
24 Mora-Gutiérrez JM, Fernández-Seara MA, Echeverria-Chasco R, Garcia-Fernandez N. Perspectives on the Role of Magnetic Resonance Imaging (MRI) for Noninvasive Evaluation of Diabetic Kidney Disease. J Clin Med 2021;10:2461. [PMID: 34199385 DOI: 10.3390/jcm10112461] [Reference Citation Analysis]
25 Perez-Rodriguez J, Lai S, Ehst BD, Fine DM, Bluemke DA. Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment--report of 33 cases. Radiology 2009;250:371-7. [PMID: 19188312 DOI: 10.1148/radiol.2502080498] [Cited by in Crossref: 177] [Cited by in F6Publishing: 130] [Article Influence: 14.8] [Reference Citation Analysis]
26 Borrero CG, Mountz JM, Mountz JD. Emerging MRI methods in rheumatoid arthritis. Nat Rev Rheumatol 2011;7:85-95. [PMID: 21045791 DOI: 10.1038/nrrheum.2010.173] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
27 Del Galdo F, Wermuth PJ, Addya S, Fortina P, Jimenez SA. NFκB activation and stimulation of chemokine production in normal human macrophages by the gadolinium-based magnetic resonance contrast agent Omniscan: possible role in the pathogenesis of nephrogenic systemic fibrosis. Ann Rheum Dis 2010;69:2024-33. [PMID: 20959327 DOI: 10.1136/ard.2010.134858] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
28 Siriwardena AK, Mason JM, Mullamitha S, Hancock HC, Jegatheeswaran S. Management of colorectal cancer presenting with synchronous liver metastases. Nat Rev Clin Oncol 2014;11:446-59. [DOI: 10.1038/nrclinonc.2014.90] [Cited by in Crossref: 75] [Cited by in F6Publishing: 62] [Article Influence: 10.7] [Reference Citation Analysis]
29 Andersen PE. Patient selection and preparation strategies for the use of contrast material in patients with chronic kidney disease. World J Radiol 2012;4:253-7. [PMID: 22778877 DOI: 10.4329/wjr.v4.i6.253] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
30 Wu G, Yang J, Zhang T, Morelli JN, Giri S, Li X, Tang W. The diagnostic value of non-contrast enhanced quiescent interval single shot (QISS) magnetic resonance angiography at 3T for lower extremity peripheral arterial disease, in comparison to CT angiography. J Cardiovasc Magn Reson 2016;18:71. [PMID: 27760564 DOI: 10.1186/s12968-016-0294-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 4.2] [Reference Citation Analysis]
31 Tan M, Ye Z, Jeong EK, Wu X, Parker DL, Lu ZR. Synthesis and evaluation of nanoglobular macrocyclic Mn(II) chelate conjugates as non-gadolinium(III) MRI contrast agents. Bioconjug Chem 2011;22:931-7. [PMID: 21473650 DOI: 10.1021/bc100573t] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
32 Edwards BJ, Laumann AE, Nardone B, Miller FH, Restaino J, Raisch DW, McKoy JM, Hammel JA, Bhatt K, Bauer K, Samaras AT, Fisher MJ, Bull C, Saddleton E, Belknap SM, Thomsen HS, Kanal E, Cowper SE, Abu Alfa AK, West DP. Advancing pharmacovigilance through academic-legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis-a Research on Adverse Drug Events and Reports (RADAR) report. Br J Radiol 2014;87:20140307. [PMID: 25230161 DOI: 10.1259/bjr.20140307] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
33 Bennett CL, Starko KM, Thomsen HS, Cowper S, Sartor O, Macdougall IC, Qureshi ZP, Bookstaver PB, Miller AD, Norris LB, Xirasagar S, Trenery A, Lopez I, Kahn A, Murday A, Luminari S, Cournoyer D, Locatelli F, Ray P, Mattison DR. Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR). J Gen Intern Med 2012;27:1697-703. [PMID: 22692632 DOI: 10.1007/s11606-012-2098-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
34 Ozgen B, Oguz B, Dolgun A. Diagnostic accuracy of the constructive interference in steady state sequence alone for follow-up imaging of vestibular schwannomas. AJNR Am J Neuroradiol 2009;30:985-91. [PMID: 19193761 DOI: 10.3174/ajnr.A1472] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
35 Wu Y, Agarwal S, Jones CK, Webb AG, van Zijl PC, Hua J, Pillai JJ. Measurement of arteriolar blood volume in brain tumors using MRI without exogenous contrast agent administration at 7T. J Magn Reson Imaging 2016;44:1244-55. [PMID: 27028493 DOI: 10.1002/jmri.25248] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
36 Pallares RM, Faulkner D, An DD, Hébert S, Loguinov A, Proctor M, Villalobos JA, Bjornstad KA, Rosen CJ, Vulpe C, Abergel RJ. Genome-wide toxicogenomic study of the lanthanides sheds light on the selective toxicity mechanisms associated with critical materials. Proc Natl Acad Sci U S A 2021;118:e2025952118. [PMID: 33903247 DOI: 10.1073/pnas.2025952118] [Reference Citation Analysis]
37 Davenport MS, Dillman JR, Cohan RH, Hussain HK, Khalatbari S, McHugh JB, Ellis JH. Effect of abrupt substitution of gadobenate dimeglumine for gadopentetate dimeglumine on rate of allergic-like reactions. Radiology 2013;266:773-82. [PMID: 23238152 DOI: 10.1148/radiol.12120253] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
38 Kálmán FK, Nagy V, Uzal-Varela R, Pérez-Lourido P, Esteban-Gómez D, Garda Z, Pota K, Mezei R, Pallier A, Tóth É, Platas-Iglesias C, Tircsó G. Expanding the Ligand Classes Used for Mn(II) Complexation: Oxa-aza Macrocycles Make the Difference. Molecules 2021;26:1524. [PMID: 33802241 DOI: 10.3390/molecules26061524] [Reference Citation Analysis]
39 Abdel-Kader K, Patel PR, Kallen AJ, Sinkowitz-Cochran RL, Bolton WK, Unruh ML. Nephrogenic systemic fibrosis: a survey of nephrologists' perceptions and practices. Clin J Am Soc Nephrol 2010;5:964-71. [PMID: 20299369 DOI: 10.2215/CJN.00140110] [Cited by in Crossref: 7] [Article Influence: 0.6] [Reference Citation Analysis]
40 Shi GZ, Chen H, Zeng WK, Gao M, Wang MZ, Zhang HT, Shen J. R2* value derived from multi-echo Dixon technique can aid discrimination between benign and malignant focal liver lesions. World J Gastroenterol 2021;27:1182-93. [PMID: 33828393 DOI: 10.3748/wjg.v27.i12.1182] [Reference Citation Analysis]
41 Li J, Jiang X, Shang L, Li Z, Yang C, Luo Y, Hu D, Shen Y, Zhang Z. L-EGCG-Mn nanoparticles as a pH-sensitive MRI contrast agent. Drug Deliv 2021;28:134-43. [PMID: 33356629 DOI: 10.1080/10717544.2020.1862363] [Reference Citation Analysis]
42 Zhou Z, Chen H, Lipowska M, Wang L, Yu Q, Yang X, Tiwari D, Yang L, Mao H. A dual-modal magnetic nanoparticle probe for preoperative and intraoperative mapping of sentinel lymph nodes by magnetic resonance and near infrared fluorescence imaging. J Biomater Appl 2013;28:100-11. [PMID: 23812946 DOI: 10.1177/0885328212437883] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
43 Kelle S, Schlendorf K, Hirsch GA, Gerstenblith G, Fleck E, Weiss RG, Stuber M. Gadolinium Enhanced MR Coronary Vessel Wall Imaging at 3.0 Tesla. Cardiol Res Pract 2010;2010:856418. [PMID: 20981285 DOI: 10.4061/2010/856418] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
44 Pushie MJ, Pickering IJ, Korbas M, Hackett MJ, George GN. Elemental and chemically specific X-ray fluorescence imaging of biological systems. Chem Rev 2014;114:8499-541. [PMID: 25102317 DOI: 10.1021/cr4007297] [Cited by in Crossref: 158] [Cited by in F6Publishing: 111] [Article Influence: 22.6] [Reference Citation Analysis]
45 Hoggard N, Roditi GH. T1 hyperintensity on brain imaging subsequent to gadolinium-based contrast agent administration: what do we know about intracranial gadolinium deposition? Br J Radiol 2017;90:20160590. [PMID: 27653560 DOI: 10.1259/bjr.20160590] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
46 Piera-Velazquez S, Louneva N, Fertala J, Wermuth PJ, Del Galdo F, Jimenez SA. Persistent activation of dermal fibroblasts from patients with gadolinium-associated nephrogenic systemic fibrosis. Ann Rheum Dis 2010;69:2017-23. [PMID: 20570839 DOI: 10.1136/ard.2009.127761] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
47 Ramanathan A. Toxicity of nanoparticles_ challenges and opportunities. Appl Microsc 2019;49:2. [PMID: 33580298 DOI: 10.1007/s42649-019-0004-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Rahbari-Oskoui F, Mittal A, Mittal P, Chapman A. Renal relevant radiology: radiologic imaging in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2014;9:406-415. [PMID: 24370765 DOI: 10.2215/cjn.08940813] [Cited by in Crossref: 31] [Cited by in F6Publishing: 7] [Article Influence: 3.9] [Reference Citation Analysis]
49 Tan S, Yang H, Xue S, Qiao J, Salarian M, Hekmatyar K, Meng Y, Mukkavilli R, Pu F, Odubade OY, Harris W, Hai Y, Yushak ML, Morales-Tirado VM, Mittal P, Sun PZ, Lawson D, Grossniklaus HE, Yang JJ. Chemokine receptor 4 targeted protein MRI contrast agent for early detection of liver metastases. Sci Adv 2020;6:eaav7504. [PMID: 32083172 DOI: 10.1126/sciadv.aav7504] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
50 Malikova H. Nephrogenic systemic fibrosis: the end of the story? Quant Imaging Med Surg 2019;9:1470-4. [PMID: 31559176 DOI: 10.21037/qims.2019.07.11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
51 Stojanov D, Aracki-Trenkic A, Benedeto-Stojanov D. Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status. Neuroradiology. 2016;58:433-441. [PMID: 26873830 DOI: 10.1007/s00234-016-1658-1] [Cited by in Crossref: 88] [Cited by in F6Publishing: 69] [Article Influence: 17.6] [Reference Citation Analysis]
52 Adabi S, Hosseinzadeh M, Noei S, Conforto S, Daveluy S, Clayton A, Mehregan D, Nasiriavanaki M. Universal in vivo Textural Model for Human Skin based on Optical Coherence Tomograms. Sci Rep 2017;7:17912. [PMID: 29263332 DOI: 10.1038/s41598-017-17398-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 10.5] [Reference Citation Analysis]
53 Thomsen HS. Imaging patients with chronic kidney disease: CIN or NSF? Radiol Med. 2007;112:621-625. [PMID: 17653629 DOI: 10.1007/s11547-007-0168-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
54 Garcia J, Liu SZ, Louie AY. Biological effects of MRI contrast agents: gadolinium retention, potential mechanisms and a role for phosphorus. Philos Trans A Math Phys Eng Sci 2017;375:20170180. [PMID: 29038383 DOI: 10.1098/rsta.2017.0180] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
55 Samtleben W. [Nephrogenic systemic fibrosis]. Radiologe 2007;47:778-84. [PMID: 17717643 DOI: 10.1007/s00117-007-1545-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
56 Beomonte Zobel B, Quattrocchi CC, Errante Y, Grasso RF. Gadolinium-based contrast agents: did we miss something in the last 25 years? Radiol Med 2016;121:478-81. [PMID: 26706453 DOI: 10.1007/s11547-015-0614-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
57 Fan Z, Sheehan J, Bi X, Liu X, Carr J, Li D. 3D noncontrast MR angiography of the distal lower extremities using flow-sensitive dephasing (FSD)-prepared balanced SSFP. Magn Reson Med 2009;62:1523-32. [PMID: 19877278 DOI: 10.1002/mrm.22142] [Cited by in Crossref: 90] [Cited by in F6Publishing: 73] [Article Influence: 8.2] [Reference Citation Analysis]
58 Hoda RS, Sanyal S, Abraham JL, Everett JM, Hundemer GL, Yee E, Lauwers GY, Tolkoff-Rubin N, Misdraji J. Lanthanum deposition from oral lanthanum carbonate in the upper gastrointestinal tract. Histopathology. 2017;70:1072-1078. [PMID: 28134986 DOI: 10.1111/his.13178] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
59 Gale EM, Wey HY, Ramsay I, Yen YF, Sosnovik DE, Caravan P. A Manganese-based Alternative to Gadolinium: Contrast-enhanced MR Angiography, Excretion, Pharmacokinetics, and Metabolism. Radiology 2018;286:865-72. [PMID: 29117483 DOI: 10.1148/radiol.2017170977] [Cited by in Crossref: 47] [Cited by in F6Publishing: 32] [Article Influence: 11.8] [Reference Citation Analysis]
60 Hua J, Brandt AS, Lee S, Blair NIS, Wu Y, Lui S, Patel J, Faria AV, Lim IAL, Unschuld PG, Pekar JJ, van Zijl PCM, Ross CA, Margolis RL. Abnormal Grey Matter Arteriolar Cerebral Blood Volume in Schizophrenia Measured With 3D Inflow-Based Vascular-Space-Occupancy MRI at 7T. Schizophr Bull 2017;43:620-32. [PMID: 27539951 DOI: 10.1093/schbul/sbw109] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
61 Shahrouki P, Moriarty JM, Khan SN, Bista B, Kee ST, DeRubertis BG, Yoshida T, Nguyen KL, Finn JP. High resolution, 3-dimensional Ferumoxytol-enhanced cardiovascular magnetic resonance venography in central venous occlusion. J Cardiovasc Magn Reson 2019;21:17. [PMID: 30853026 DOI: 10.1186/s12968-019-0528-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
62 Wang ST, Hua ZX, Fan DX, Zhang X, Ren K. Gadolinium Retention and Clearance in the Diabetic Brain after Administrations of Gadodiamide, Gadopentetate Dimeglumine, and Gadoterate Meglumine in a Rat Model. Biomed Res Int 2019;2019:3901907. [PMID: 31192255 DOI: 10.1155/2019/3901907] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
63 Sadowski EA, Djamali A, Wentland AL, Muehrer R, Becker BN, Grist TM, Fain SB. Blood oxygen level-dependent and perfusion magnetic resonance imaging: detecting differences in oxygen bioavailability and blood flow in transplanted kidneys. Magn Reson Imaging. 2010;28:56-64. [PMID: 19577402 DOI: 10.1016/j.mri.2009.05.044] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
64 Bernard ED, Beking MA, Rajamanickam K, Tsai EC, Derosa MC. Target binding improves relaxivity in aptamer-gadolinium conjugates. J Biol Inorg Chem 2012;17:1159-75. [PMID: 22903502 DOI: 10.1007/s00775-012-0930-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
65 Charlton JR, Beeman SC, Bennett KM. MRI-detectable nanoparticles: the potential role in the diagnosis of and therapy for chronic kidney disease. Adv Chronic Kidney Dis. 2013;20:479-487. [PMID: 24206600 DOI: 10.1053/j.ackd.2013.06.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
66 Ramalho J, Semelka RC, Ramalho M, Nunes RH, AlObaidy M, Castillo M. Gadolinium-Based Contrast Agent Accumulation and Toxicity: An Update. AJNR Am J Neuroradiol 2016;37:1192-8. [PMID: 26659341 DOI: 10.3174/ajnr.A4615] [Cited by in Crossref: 218] [Cited by in F6Publishing: 68] [Article Influence: 36.3] [Reference Citation Analysis]
67 Kamesh Iyer S, Moon B, Hwuang E, Han Y, Solomon M, Litt H, Witschey WR. Accelerated free-breathing 3D T1ρ cardiovascular magnetic resonance using multicoil compressed sensing. J Cardiovasc Magn Reson 2019;21:5. [PMID: 30626437 DOI: 10.1186/s12968-018-0507-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
68 Perone PA, Weber SL, DaSilva M, Paruchuri T, Bhagavathula N, Aslam MN, Dame MK, Johnson KJ, Swartz RD, Varani J. Collagenolytic activity is suppressed in organ-cultured human skin exposed to a gadolinium-based MRI contrast agent. Invest Radiol 2010;45:42-8. [PMID: 19996758 DOI: 10.1097/RLI.0b013e3181bf95eb] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
69 Wermuth PJ, Del Galdo F, Jiménez SA. Induction of the expression of profibrotic cytokines and growth factors in normal human peripheral blood monocytes by gadolinium contrast agents. Arthritis Rheum 2009;60:1508-18. [PMID: 19404939 DOI: 10.1002/art.24471] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 4.7] [Reference Citation Analysis]
70 Falk Delgado A, De Luca F, van Westen D, Falk Delgado A. Arterial spin labeling MR imaging for differentiation between high- and low-grade glioma-a meta-analysis. Neuro Oncol 2018;20:1450-61. [PMID: 29868920 DOI: 10.1093/neuonc/noy095] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
71 Basak P, Jesmajian S. Nephrogenic systemic fibrosis: current concepts. Indian J Dermatol 2011;56:59-64. [PMID: 21572795 DOI: 10.4103/0019-5154.77555] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
72 Hanna RF, Finkelstone LA, Chow DS, Miloushev VZ, Escudero MR, Lagana SM, Prince MR. Nephrogenic systemic fibrosis risk and liver disease. Int J Nephrol 2014;2014:679605. [PMID: 24778878 DOI: 10.1155/2014/679605] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
73 Deray G, Rouviere O, Bacigalupo L, Maes B, Hannedouche T, Vrtovsnik F, Rigothier C, Billiouw JM, Campioni P, Ferreiros J, Devos D, Alison D, Glowacki F, Boffa JJ, Marti-Bonmati L. Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study). Eur Radiol. 2013;23:1250-1259. [PMID: 23212275 DOI: 10.1007/s00330-012-2705-x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
74 Safley DM, Salisbury AC, Tsai TT, Secemsky EA, Kennedy KF, Rogers RK, Latif F, Shammas NW, Garcia L, Cavender MA, Rosenfield K, Prasad A, Spertus JA. Acute Kidney Injury Following In-Patient Lower Extremity Vascular Intervention: From the National Cardiovascular Data Registry. JACC Cardiovasc Interv 2021;14:333-41. [PMID: 33541543 DOI: 10.1016/j.jcin.2020.10.028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
75 Inker LA, Tonelli M, Hemmelgarn BR, Levitan EB, Muntner P. Comparison of concurrent complications of CKD by 2 risk categorization systems. Am J Kidney Dis 2012;59:372-81. [PMID: 22113126 DOI: 10.1053/j.ajkd.2011.09.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
76 Sivasubramanian M, Chuang YC, Chen NT, Lo LW. Seeing Better and Going Deeper in Cancer Nanotheranostics. Int J Mol Sci 2019;20:E3490. [PMID: 31315232 DOI: 10.3390/ijms20143490] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
77 Elmholdt TR, Olesen AB, Jørgensen B, Kvist S, Skov L, Thomsen HS, Marckmann P, Pedersen M. Nephrogenic systemic fibrosis in Denmark--a nationwide investigation. PLoS One 2013;8:e82037. [PMID: 24349178 DOI: 10.1371/journal.pone.0082037] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
78 Boertien WE, Meijer E, Li J, Bost JE, Struck J, Flessner MF, Gansevoort RT, Torres VE; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease CRISP. Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CRISP cohort. Am J Kidney Dis. 2013;61:420-429. [PMID: 23089511 DOI: 10.1053/j.ajkd.2012.08.038] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 6.7] [Reference Citation Analysis]
79 Torres VE, Grantham JJ, Chapman AB, Mrug M, Bae KT, King BF Jr, Wetzel LH, Martin D, Lockhart ME, Bennett WM, Moxey-Mims M, Abebe KZ, Lin Y, Bost JE; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP). Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2011;6:640-7. [PMID: 21088290 DOI: 10.2215/CJN.03250410] [Cited by in Crossref: 85] [Cited by in F6Publishing: 44] [Article Influence: 7.7] [Reference Citation Analysis]
80 Klem I, Weinsaft JW, Bahnson TD, Hegland D, Kim HW, Hayes B, Parker MA, Judd RM, Kim RJ. Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J Am Coll Cardiol. 2012;60:408-420. [PMID: 22835669 DOI: 10.1016/j.jacc.2012.02.070] [Cited by in Crossref: 210] [Cited by in F6Publishing: 160] [Article Influence: 23.3] [Reference Citation Analysis]
81 Schneider G, Schürholz H, Kirchin MA, Bücker A, Fries P. Safety and adverse effects during 24 hours after contrast-enhanced MRI with gadobenate dimeglumine (MultiHance) in children. Pediatr Radiol 2013;43:202-11. [PMID: 23179483 DOI: 10.1007/s00247-012-2498-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
82 Pasquini L, Napolitano A, Visconti E, Longo D, Romano A, Tomà P, Rossi Espagnet MC. Gadolinium-Based Contrast Agent-Related Toxicities. CNS Drugs 2018;32:229-40. [PMID: 29508245 DOI: 10.1007/s40263-018-0500-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 17.0] [Reference Citation Analysis]
83 Le Fur M, Rotile NJ, Correcher C, Clavijo Jordan V, Ross AW, Catana C, Caravan P. Yttrium-86 Is a Positron Emitting Surrogate of Gadolinium for Noninvasive Quantification of Whole-Body Distribution of Gadolinium-Based Contrast Agents. Angew Chem Int Ed Engl 2020;59:1474-8. [PMID: 31750991 DOI: 10.1002/anie.201911858] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
84 Thomsen HS, Marckmann P, Logager VB. Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents. Cancer Imaging 2007;7:130-7. [PMID: 17905680 DOI: 10.1102/1470-7330.2007.0019] [Cited by in Crossref: 84] [Cited by in F6Publishing: 64] [Article Influence: 6.0] [Reference Citation Analysis]
85 Schneider AG, Goodwin MD, Bellomo R. Measurement of kidney perfusion in critically ill patients. Crit Care 2013;17:220. [PMID: 23514525 DOI: 10.1186/cc12529] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
86 Boin F, Hummers LK. Scleroderma-like fibrosing disorders. Rheum Dis Clin North Am 2008;34:199-220; ix. [PMID: 18329541 DOI: 10.1016/j.rdc.2007.11.001] [Cited by in Crossref: 81] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
87 Schroeder JA, Weingart C, Coras B, Hausser I, Reinhold S, Mack M, Seybold V, Vogt T, Banas B, Hofstaedter F, Krämer BK. Ultrastructural evidence of dermal gadolinium deposits in a patient with nephrogenic systemic fibrosis and end-stage renal disease. Clin J Am Soc Nephrol 2008;3:968-75. [PMID: 18385397 DOI: 10.2215/CJN.00100108] [Cited by in Crossref: 63] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
88 Weinreb JC, Rodby RA, Yee J, Wang CL, Fine D, McDonald RJ, Perazella MA, Dillman JR, Davenport MS. Use of Intravenous Gadolinium-Based Contrast Media in Patients With Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation. Kidney Med 2021;3:142-50. [PMID: 33604544 DOI: 10.1016/j.xkme.2020.10.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
89 Bennett CL, Hoque S, Olivieri N, Taylor MA, Aboulafia D, Lubaczewski C, Bennett AC, Vemula J, Schooley B, Witherspoon BJ, Godwin AC, Ray PS, Yarnold PR, Ausdenmoore HC, Fishman M, Herring G, Ventrone A, Aldaco J, Hrushesky WJ, Restaino J, Thomsen HS, Yarnold PR, Marx R, Migliorati C, Ruggiero S, Nabhan C, Carson KR, McKoy JM, Yang YT, Schoen MW, Knopf K, Martin L, Sartor O, Rosen S, Smith WK. Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997-2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR). EClinicalMedicine 2021;31:100693. [PMID: 33554084 DOI: 10.1016/j.eclinm.2020.100693] [Reference Citation Analysis]
90 Farrar CT, Gale EM, Kennan R, Ramsay I, Masia R, Arora G, Looby K, Wei L, Kalpathy-Cramer J, Bunzel MM, Zhang C, Zhu Y, Akiyama TE, Klimas M, Pinto S, Diyabalanage H, Tanabe KK, Humblet V, Fuchs BC, Caravan P. CM-101: Type I Collagen-targeted MR Imaging Probe for Detection of Liver Fibrosis. Radiology 2018;287:581-9. [PMID: 29156148 DOI: 10.1148/radiol.2017170595] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
91 MacFarland DK, Walker KL, Lenk RP, Wilson SR, Kumar K, Kepley CL, Garbow JR. Hydrochalarones: a novel endohedral metallofullerene platform for enhancing magnetic resonance imaging contrast. J Med Chem 2008;51:3681-3. [PMID: 18558670 DOI: 10.1021/jm800521j] [Cited by in Crossref: 45] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
92 Cukur T, Lee JH, Bangerter NK, Hargreaves BA, Nishimura DG. Non-contrast-enhanced flow-independent peripheral MR angiography with balanced SSFP. Magn Reson Med 2009;61:1533-9. [PMID: 19365850 DOI: 10.1002/mrm.21921] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
93 Shen D, Edelman RR, Robinson JD, Haji-Valizadeh H, Messina M, Giri S, Koktzoglou I, Rigsby CK, Kim D. Single-Shot Coronary Quiescent-Interval Slice-Selective Magnetic Resonance Angiography Using Compressed Sensing: A Feasibility Study in Patients With Congenital Heart Disease. J Comput Assist Tomogr 2018;42:739-46. [PMID: 29958198 DOI: 10.1097/RCT.0000000000000760] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
94 Lansberg MG, Thijs VN, Bammer R, Olivot JM, Marks MP, Wechsler LR, Kemp S, Albers GW. The MRA-DWI mismatch identifies patients with stroke who are likely to benefit from reperfusion. Stroke. 2008;39:2491-2496. [PMID: 18635861 DOI: 10.1161/strokeaha.107.508572] [Cited by in Crossref: 81] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
95 Bulte JWM, Daldrup-Link HE. Clinical Tracking of Cell Transfer and Cell Transplantation: Trials and Tribulations. Radiology 2018;289:604-15. [PMID: 30299232 DOI: 10.1148/radiol.2018180449] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 13.0] [Reference Citation Analysis]
96 Bharwani N, Koh DM. Diffusion-weighted imaging of the liver: an update. Cancer Imaging 2013;13:171-85. [PMID: 23598460 DOI: 10.1102/1470-7330.2013.0019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
97 Bhave G, Lewis JB, Chang SS. Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis. J Urol 2008;180:830-5; discussion 835. [PMID: 18635232 DOI: 10.1016/j.juro.2008.05.005] [Cited by in Crossref: 50] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
98 Uhlig J, Lücke C, Vliegenthart R, Loewe C, Grothoff M, Schuster A, Lurz P, Jacquier A, Francone M, Zapf A, Schülke C, May MS, Bremerich J, Lotz J, Gutberlet M; Daniel Thomas., ESCR MRCT Registry contributors. Acute adverse events in cardiac MR imaging with gadolinium-based contrast agents: results from the European Society of Cardiovascular Radiology (ESCR) MRCT Registry in 72,839 patients. Eur Radiol 2019;29:3686-95. [PMID: 31041566 DOI: 10.1007/s00330-019-06171-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 9.5] [Reference Citation Analysis]
99 Zou Z, Ma L. Nephrogenic systemic fibrosis: review of 408 biopsy-confirmed cases. Indian J Dermatol. 2011;56:65-73. [PMID: 21572796 DOI: 10.4103/0019-5154.77556] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
100 Bhagavathula N, Dame MK, DaSilva M, Jenkins W, Aslam MN, Perone P, Varani J. Fibroblast response to gadolinium: role for platelet-derived growth factor receptor. Invest Radiol 2010;45:769-77. [PMID: 20714270 DOI: 10.1097/RLI.0b013e3181e943d2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
101 Tan H, Thacker J, Franklin T, Prasad PV. Sensitivity of arterial spin labeling perfusion MRI to pharmacologically induced perfusion changes in rat kidneys. J Magn Reson Imaging 2015;41:1124-8. [PMID: 24796852 DOI: 10.1002/jmri.24645] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
102 Do C, DeAguero J, Brearley A, Trejo X, Howard T, Escobar GP, Wagner B. Gadolinium-Based Contrast Agent Use, Their Safety, and Practice Evolution. Kidney360 2020;1:561-8. [PMID: 34423308 DOI: 10.34067/kid.0000272019] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
103 Steen H, Schwenger V. Good MRI images: to Gad or not to Gad? Pediatr Nephrol 2007;22:1239-42. [PMID: 17574478 DOI: 10.1007/s00467-007-0509-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
104 McDonald ES, Hammersley JA, Chou SH, Rahbar H, Scheel JR, Lee CI, Liu CL, Lehman CD, Partridge SC. Performance of DWI as a Rapid Unenhanced Technique for Detecting Mammographically Occult Breast Cancer in Elevated-Risk Women With Dense Breasts. AJR Am J Roentgenol 2016;207:205-16. [PMID: 27077731 DOI: 10.2214/AJR.15.15873] [Cited by in Crossref: 42] [Cited by in F6Publishing: 15] [Article Influence: 8.4] [Reference Citation Analysis]
105 Robic C, Port M, Rousseaux O, Louguet S, Fretellier N, Catoen S, Factor C, Le Greneur S, Medina C, Bourrinet P, Raynal I, Idée JM, Corot C. Physicochemical and Pharmacokinetic Profiles of Gadopiclenol: A New Macrocyclic Gadolinium Chelate With High T1 Relaxivity. Invest Radiol 2019;54:475-84. [PMID: 30973459 DOI: 10.1097/RLI.0000000000000563] [Cited by in Crossref: 17] [Cited by in F6Publishing: 1] [Article Influence: 17.0] [Reference Citation Analysis]
106 Tan H, Koktzoglou I, Prasad PV. Renal perfusion imaging with two-dimensional navigator gated arterial spin labeling. Magn Reson Med 2014;71:570-9. [PMID: 23447145 DOI: 10.1002/mrm.24692] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
107 Textor SC, Glockner JF, Lerman LO, Misra S, McKusick MA, Riederer SJ, Grande JP, Gomez SI, Romero JC. The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis. J Am Soc Nephrol 2008;19:780-8. [PMID: 18287564 DOI: 10.1681/ASN.2007040420] [Cited by in Crossref: 118] [Cited by in F6Publishing: 54] [Article Influence: 9.1] [Reference Citation Analysis]
108 Metzger GJ, Auerbach EJ, Akgun C, Simonson J, Bi X, Uğurbil K, van de Moortele PF. Dynamically applied B1+ shimming solutions for non-contrast enhanced renal angiography at 7.0 Tesla. Magn Reson Med 2013;69:114-26. [PMID: 22442056 DOI: 10.1002/mrm.24237] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
109 Ghio AJ, Soukup JM, Dailey LA, Richards J, Deng Z, Abraham JL. Gadolinium exposure disrupts iron homeostasis in cultured cells. J Biol Inorg Chem 2011;16:567-75. [PMID: 21267611 DOI: 10.1007/s00775-011-0757-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
110 Taouli B, Ehman RL, Reeder SB. Advanced MRI methods for assessment of chronic liver disease. AJR Am J Roentgenol. 2009;193:14-27. [PMID: 19542391 DOI: 10.2214/ajr.09.2601] [Cited by in Crossref: 128] [Cited by in F6Publishing: 44] [Article Influence: 10.7] [Reference Citation Analysis]
111 Wadas TJ, Sherman CD, Miner JH, Duncan JR, Anderson CJ. The biodistribution of [153Gd]Gd-labeled magnetic resonance contrast agents in a transgenic mouse model of renal failure differs greatly from control mice. Magn Reson Med 2010;64:1274-80. [PMID: 20648683 DOI: 10.1002/mrm.22553] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
112 Zhou Z, Wang L, Chi X, Bao J, Yang L, Zhao W, Chen Z, Wang X, Chen X, Gao J. Engineered iron-oxide-based nanoparticles as enhanced T1 contrast agents for efficient tumor imaging. ACS Nano 2013;7:3287-96. [PMID: 23473444 DOI: 10.1021/nn305991e] [Cited by in Crossref: 168] [Cited by in F6Publishing: 139] [Article Influence: 21.0] [Reference Citation Analysis]
113 Choi JW, Moon WJ. Gadolinium Deposition in the Brain: Current Updates.Korean J Radiol. 2019;20:134-147. [PMID: 30627029 DOI: 10.3348/kjr.2018.0356] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 18.3] [Reference Citation Analysis]
114 Vlijm A, van Schuppen J, Lamers AB, Struijk DG, Krediet RT. Imaging in encapsulating peritoneal sclerosis. NDT Plus 2011;4:281-4. [PMID: 25984169 DOI: 10.1093/ndtplus/sfr068] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
115 Rasche V, Oberhuber A, Trumpp S, Bornstedt A, Orend KH, Merkle N, Rottbauer W, Hoffmann M. MRI assessment of thoracic stent grafts after emergency implantation in multi trauma patients: a feasibility study. Eur Radiol 2011;21:1397-405. [PMID: 21331596 DOI: 10.1007/s00330-011-2074-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
116 Kromrey ML, Liedtke KR, Ittermann T, Langner S, Kirsch M, Weitschies W, Kühn JP. Intravenous injection of gadobutrol in an epidemiological study group did not lead to a difference in relative signal intensities of certain brain structures after 5 years. Eur Radiol 2017;27:772-7. [PMID: 27221561 DOI: 10.1007/s00330-016-4418-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
117 Wang J, Salzillo T, Jiang Y, Mackeyev Y, David Fuller C, Chung C, Choi S, Hughes N, Ding Y, Yang J, Vedam S, Krishnan S. Stability of MRI contrast agents in high-energy radiation of a 1.5T MR-Linac. Radiother Oncol 2021;161:55-64. [PMID: 34089753 DOI: 10.1016/j.radonc.2021.05.023] [Reference Citation Analysis]
118 Wagner B, Drel V, Gorin Y. Pathophysiology of gadolinium-associated systemic fibrosis. Am J Physiol Renal Physiol 2016;311:F1-F11. [PMID: 27147669 DOI: 10.1152/ajprenal.00166.2016] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 6.2] [Reference Citation Analysis]
119 Leiner T, Herborn CU, Goyen M. Nephrogenic systemic fibrosis is not exclusively associated with gadodiamide. Eur Radiol 2007;17:1921-3. [PMID: 17458550 DOI: 10.1007/s00330-007-0663-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
120 Pu F, Qiao J, Xue S, Yang H, Patel A, Wei L, Hekmatyar K, Salarian M, Grossniklaus HE, Liu ZR, Yang JJ. GRPR-targeted Protein Contrast Agents for Molecular Imaging of Receptor Expression in Cancers by MRI. Sci Rep 2015;5:16214. [PMID: 26577829 DOI: 10.1038/srep16214] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
121 Dai L, Jones CM, Chan WTK, Pham TA, Ling X, Gale EM, Rotile NJ, Tai WC, Anderson CJ, Caravan P, Law GL. Chiral DOTA chelators as an improved platform for biomedical imaging and therapy applications. Nat Commun 2018;9:857. [PMID: 29487362 DOI: 10.1038/s41467-018-03315-8] [Cited by in Crossref: 37] [Cited by in F6Publishing: 22] [Article Influence: 12.3] [Reference Citation Analysis]
122 Michaely HJ, Aschauer M, Deutschmann H, Bongartz G, Gutberlet M, Woitek R, Ertl-Wagner B, Kucharczyk W, Hammerstingl R, De Cobelli F, Rosenberg M, Balzer T, Endrikat J. Gadobutrol in Renally Impaired Patients: Results of the GRIP Study. Invest Radiol 2017;52:55-60. [PMID: 27529464 DOI: 10.1097/RLI.0000000000000307] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
123 Meloni A, Montanaro D, De Marchi D, Resta M, Keilberg P, Pistoia L, Positano V, Spasiano A, Casini T, De Bari CC, De Cori S, Pepe A. Absence of T1 Hyperintensity in the Brain of High-risk Patients After Multiple Administrations of High-dose Gadobutrol for Cardiac Magnetic Resonance. Clin Neuroradiol 2021;31:347-55. [PMID: 32185401 DOI: 10.1007/s00062-020-00897-z] [Reference Citation Analysis]
124 Jinzaki M, Kitagawa K, Tsai IC, Chan C, Yu W, Yong HS, Choi BW; ASCI CCT & CMR Guideline Working Group. ASCI 2010 contrast media guideline for cardiac imaging: a report of the Asian Society of Cardiovascular Imaging cardiac computed tomography and cardiac magnetic resonance imaging guideline working group. Int J Cardiovasc Imaging 2010;26:203-12. [PMID: 20931289 DOI: 10.1007/s10554-010-9691-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
125 Costelloe CM, Murphy WA Jr, Haygood TM, Kumar R, McEnery KW, Stafford RJ, Roy A, Bassett RL Jr, Harrell RK, Madewell JE. Comparison of half-dose and full-dose gadolinium MR contrast on the enhancement of bone and soft tissue tumors. Skeletal Radiol 2011;40:327-33. [PMID: 20862469 DOI: 10.1007/s00256-010-1028-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
126 Ersoy H, Rybicki FJ. Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis. J Magn Reson Imaging 2007;26:1190-7. [PMID: 17969161 DOI: 10.1002/jmri.21135] [Cited by in Crossref: 186] [Cited by in F6Publishing: 140] [Article Influence: 14.3] [Reference Citation Analysis]
127 Sammet S. Magnetic resonance safety. Abdom Radiol (NY) 2016;41:444-51. [PMID: 26940331 DOI: 10.1007/s00261-016-0680-4] [Cited by in Crossref: 54] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
128 Lauenstein T, Ramirez-Garrido F, Kim YH, Rha SE, Ricke J, Phongkitkarun S, Boettcher J, Gupta RT, Korpraphong P, Tanomkiat W, Furtner J, Liu PS, Henry M, Endrikat J. Nephrogenic systemic fibrosis risk after liver magnetic resonance imaging with gadoxetate disodium in patients with moderate to severe renal impairment: results of a prospective, open-label, multicenter study. Invest Radiol 2015;50:416-22. [PMID: 25756684 DOI: 10.1097/RLI.0000000000000145] [Cited by in Crossref: 39] [Cited by in F6Publishing: 7] [Article Influence: 7.8] [Reference Citation Analysis]
129 Seminara NM, Gelfand JM. Assessing long-term drug safety: lessons (re) learned from raptiva. Semin Cutan Med Surg 2010;29:16-9. [PMID: 20430303 DOI: 10.1016/j.sder.2010.01.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
130 Kim HW, Klem I, Shah DJ, Wu E, Meyers SN, Parker MA, Crowley AL, Bonow RO, Judd RM, Kim RJ. Unrecognized non-Q-wave myocardial infarction: prevalence and prognostic significance in patients with suspected coronary disease. PLoS Med 2009;6:e1000057. [PMID: 19381280 DOI: 10.1371/journal.pmed.1000057] [Cited by in Crossref: 87] [Cited by in F6Publishing: 67] [Article Influence: 7.3] [Reference Citation Analysis]
131 Morgan ND, Hummers LK. Scleroderma Mimickers. Curr Treatm Opt Rheumatol 2016;2:69-84. [PMID: 28473954 DOI: 10.1007/s40674-016-0038-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
132 Galperin TA, Cronin AJ, Leslie KS. Cutaneous manifestations of ESRD. Clin J Am Soc Nephrol. 2014;9:201-218. [PMID: 24115194 DOI: 10.2215/cjn.05900513] [Cited by in Crossref: 32] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
133 Zhang YL, Yu BL, Ren J, Qu K, Wang K, Qiang YQ, Li CX, Sun XW. EADC Values in Diagnosis of Renal Lesions by 3.0 T Diffusion-Weighted Magnetic Resonance Imaging: Compared with the ADC Values. Appl Magn Reson 2013;44:349-63. [PMID: 23476099 DOI: 10.1007/s00723-012-0376-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
134 Park HS, Han JK, Lee JM, Kim YI, Woo S, Yoon JH, Choi JY, Choi BI. Dynamic Contrast-Enhanced MRI Using a Macromolecular MR Contrast Agent (P792): Evaluation of Antivascular Drug Effect in a Rabbit VX2 Liver Tumor Model. Korean J Radiol 2015;16:1029-37. [PMID: 26357497 DOI: 10.3348/kjr.2015.16.5.1029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
135 Ranga A, Agarwal Y, Garg KJ. Gadolinium based contrast agents in current practice: Risks of accumulation and toxicity in patients with normal renal function. Indian J Radiol Imaging 2017;27:141-7. [PMID: 28744073 DOI: 10.4103/0971-3026.209212] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 29.0] [Reference Citation Analysis]
136 Le Goff S, Barrat JA, Chauvaud L, Paulet YM, Gueguen B, Ben Salem D. Compound-specific recording of gadolinium pollution in coastal waters by great scallops. Sci Rep 2019;9:8015. [PMID: 31142781 DOI: 10.1038/s41598-019-44539-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 8.5] [Reference Citation Analysis]
137 Takahashi EA, Kallmes DF, Mara KC, Harmsen WS, Misra S. Nephrotoxicity of gadolinium-based contrast in the setting of renal artery intervention: retrospective analysis with 10-year follow-up. Diagn Interv Radiol 2018;24:378-84. [PMID: 30406762 DOI: 10.5152/dir.2018.18172] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
138 Bhargava V, Singh K, Meena P, Sanyal R. Nephrogenic systemic fibrosis: A frivolous entity. World J Nephrol 2021;10:29-36. [PMID: 34136369 DOI: 10.5527/wjn.v10.i3.29] [Reference Citation Analysis]
139 Rodríguez-Rodríguez A, Shuvaev S, Rotile N, Jones CM, Probst CK, Dos Santos Ferreira D, Graham-O Regan K, Boros E, Knipe RS, Griffith JW, Tager AM, Bogdanov A Jr, Caravan P. Peroxidase Sensitive Amplifiable Probe for Molecular Magnetic Resonance Imaging of Pulmonary Inflammation. ACS Sens 2019;4:2412-9. [PMID: 31397156 DOI: 10.1021/acssensors.9b01010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
140 Thomas MA, Hazany S, Ellingson BM, Hu P, Nguyen KL. Pathophysiology, classification, and MRI parallels in microvascular disease of the heart and brain. Microcirculation 2020;27:e12648. [PMID: 32640064 DOI: 10.1111/micc.12648] [Reference Citation Analysis]
141 Das S, Parga K, Chakraborty I, Tinoco AD, Delgado Y, López PM, Fernández Vega L, Sanakis Y, Ghosh S, Bankson J, Klostergaard J, González-Méndez R, Raptis RG. Magnetic resonance imaging contrast enhancement in vitro and in vivo by octanuclear iron-oxo cluster-based agents. J Inorg Biochem 2018;186:176-86. [PMID: 29957454 DOI: 10.1016/j.jinorgbio.2018.06.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
142 Thomsen HS. Nephrogenic systemic fibrosis: A serious late adverse reaction to gadodiamide. Eur Radiol. 2006;16:2619-2621. [PMID: 17061066 DOI: 10.1007/s00330-006-0495-8] [Cited by in Crossref: 261] [Cited by in F6Publishing: 189] [Article Influence: 17.4] [Reference Citation Analysis]
143 Choi JA, Gold GE. MR imaging of articular cartilage physiology. Magn Reson Imaging Clin N Am 2011;19:249-82. [PMID: 21665090 DOI: 10.1016/j.mric.2011.02.010] [Cited by in Crossref: 80] [Cited by in F6Publishing: 64] [Article Influence: 8.0] [Reference Citation Analysis]
144 Thomsen HS, Morcos SK, Almén T, Bellin MF, Bertolotto M, Bongartz G, Clement O, Leander P, Heinz-Peer G, Reimer P. Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol. 2013;23:307-318. [PMID: 22865271 DOI: 10.1007/s00330-012-2597-9] [Cited by in Crossref: 305] [Cited by in F6Publishing: 217] [Article Influence: 33.9] [Reference Citation Analysis]
145 Tan M, Wu X, Jeong EK, Chen Q, Parker DL, Lu ZR. An effective targeted nanoglobular manganese(II) chelate conjugate for magnetic resonance molecular imaging of tumor extracellular matrix. Mol Pharm 2010;7:936-43. [PMID: 20481565 DOI: 10.1021/mp100054m] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
146 Zhang B, Liang L, Chen W, Liang C, Zhang S. An Updated Study to Determine Association between Gadolinium-Based Contrast Agents and Nephrogenic Systemic Fibrosis. PLoS One 2015;10:e0129720. [PMID: 26076348 DOI: 10.1371/journal.pone.0129720] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
147 Greenbaum LA. Renal dysplasia and MRI: a clinician's perspective. Pediatr Radiol 2008;38 Suppl 1:S70-5. [PMID: 18071696 DOI: 10.1007/s00247-007-0586-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
148 Abdullah OM, Drakos SG, Diakos NA, Wever-Pinzon O, Kfoury AG, Stehlik J, Selzman CH, Reid BB, Brunisholz K, Verma DR, Myrick C, Sachse FB, Li DY, Hsu EW. Characterization of diffuse fibrosis in the failing human heart via diffusion tensor imaging and quantitative histological validation. NMR Biomed 2014;27:1378-86. [PMID: 25200106 DOI: 10.1002/nbm.3200] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
149 Cui C, Wang S, Lu M, Duan X, Wang H, Jia L, Tang Y, Sirajuddin A, Prasad SK, Kellman P, Arai AE, Zhao S. Detection of Recent Myocardial Infarction Using Native T1 Mapping in a Swine Model: A Validation Study. Sci Rep 2018;8:7391. [PMID: 29743511 DOI: 10.1038/s41598-018-25693-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
150 Rees JA, Deblonde GJ, An DD, Ansoborlo C, Gauny SS, Abergel RJ. Evaluating the potential of chelation therapy to prevent and treat gadolinium deposition from MRI contrast agents. Sci Rep 2018;8:4419. [PMID: 29535330 DOI: 10.1038/s41598-018-22511-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 8.7] [Reference Citation Analysis]
151 Penfield JG. Nephrogenic systemic fibrosis and the use of gadolinium-based contrast agents. Pediatr Nephrol 2008;23:2121-9. [PMID: 18543004 DOI: 10.1007/s00467-008-0862-6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
152 Reiter T, Ritter O, Prince MR, Nordbeck P, Wanner C, Nagel E, Bauer WR. Minimizing risk of nephrogenic systemic fibrosis in cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2012;14:31. [PMID: 22607376 DOI: 10.1186/1532-429X-14-31] [Cited by in Crossref: 62] [Cited by in F6Publishing: 22] [Article Influence: 6.9] [Reference Citation Analysis]
153 Le Fur M, Caravan P. The biological fate of gadolinium-based MRI contrast agents: a call to action for bioinorganic chemists. Metallomics 2019;11:240-54. [PMID: 30516229 DOI: 10.1039/c8mt00302e] [Cited by in Crossref: 55] [Cited by in F6Publishing: 13] [Article Influence: 55.0] [Reference Citation Analysis]
154 Uhlig J, Al-Bourini O, Salgado R, Francone M, Vliegenthart R, Bremerich J, Lotz J, Gutberlet M. Gadolinium-based Contrast Agents for Cardiac MRI: Use of Linear and Macrocyclic Agents with Associated Safety Profile from 154 779 European Patients. Radiol Cardiothorac Imaging 2020;2:e200102. [PMID: 33778622 DOI: 10.1148/ryct.2020200102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
155 Tsushima Y, Kanal E, Thomsen HS. Nephrogenic systemic fibrosis: risk factors suggested from Japanese published cases. Br J Radiol 2010;83:590-5. [PMID: 20413447 DOI: 10.1259/bjr/17689538] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
156 Young LK, Matthew SZ, Houston JG. Absence of potential gadolinium toxicity symptoms following 22,897 gadoteric acid (Dotarem®) examinations, including 3,209 performed on renally insufficient individuals. Eur Radiol 2019;29:1922-30. [PMID: 30276674 DOI: 10.1007/s00330-018-5737-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
157 Zhang N, Fan Z, Luo N, Bi X, Zhao Y, An J, Liu J, Chen Z, Fan Z, Li D. Noncontrast MR angiography (MRA) of infragenual arteries using flow-sensitive dephasing (FSD)-prepared steady-state free precession (SSFP) at 3.0 Tesla: Comparison with contrast-enhanced MRA. J Magn Reson Imaging 2016;43:364-72. [PMID: 26185106 DOI: 10.1002/jmri.25003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
158 Yuan J, Wong OL, Lo GG, Chan HH, Wong TT, Cheung PS. Statistical assessment of bi-exponential diffusion weighted imaging signal characteristics induced by intravoxel incoherent motion in malignant breast tumors. Quant Imaging Med Surg 2016;6:418-29. [PMID: 27709078 DOI: 10.21037/qims.2016.08.05] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
159 Yu S, Yan L, Yao Y, Wang S, Yang M, Wang B, Zhuo Y, Ai L, Miao X, Zhao J, Wang DJ. Noncontrast dynamic MRA in intracranial arteriovenous malformation (AVM), comparison with time of flight (TOF) and digital subtraction angiography (DSA). Magn Reson Imaging 2012;30:869-77. [PMID: 22521994 DOI: 10.1016/j.mri.2012.02.027] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
160 Huynh K, Baghdanian AH, Baghdanian AA, Sun DS, Kolli KP, Zagoria RJ. Updated guidelines for intravenous contrast use for CT and MRI. Emerg Radiol 2020;27:115-26. [PMID: 31925592 DOI: 10.1007/s10140-020-01751-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
161 DaSilva M, O'Brien Deming M, Fligiel SE, Dame MK, Johnson KJ, Swartz RD, Varani J. Responses of human skin in organ culture and human skin fibroblasts to a gadolinium-based MRI contrast agent: comparison of skin from patients with end-stage renal disease and skin from healthy subjects. Invest Radiol 2010;45:733-9. [PMID: 20661146 DOI: 10.1097/RLI.0b013e3181e9436b] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
162 Wang L, Mohan C. Contrast-enhanced ultrasound: A promising method for renal microvascular perfusion evaluation. J Transl Int Med. 2016;4:104-108. [PMID: 28191530 DOI: 10.1515/jtim-2016-0033] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
163 Guo BJ, Yang ZL, Zhang LJ. Gadolinium Deposition in Brain: Current Scientific Evidence and Future Perspectives. Front Mol Neurosci 2018;11:335. [PMID: 30294259 DOI: 10.3389/fnmol.2018.00335] [Cited by in Crossref: 65] [Cited by in F6Publishing: 51] [Article Influence: 21.7] [Reference Citation Analysis]
164 Lange S, Mędrzycka-Dąbrowska W, Zorena K, Dąbrowski S, Ślęzak D, Malecka-Dubiela A, Rutkowski P. Nephrogenic Systemic Fibrosis as a Complication after Gadolinium-Containing Contrast Agents: A Rapid Review. Int J Environ Res Public Health 2021;18:3000. [PMID: 33804005 DOI: 10.3390/ijerph18063000] [Reference Citation Analysis]
165 Logan A, Zuppan C, Pi A, Zhang Z, Jaipaul N. Rare and unusual clinicopathologic presentation of renal AL amyloidosis. JRSM Open 2016;7:2054270416640156. [PMID: 27186381 DOI: 10.1177/2054270416640156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
166 Bongartz G. Imaging in the time of NFD/NSF: do we have to change our routines concerning renal insufficiency? MAGMA 2007;20:57-62. [PMID: 17436028 DOI: 10.1007/s10334-007-0071-5] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
167 Zhang JL, Rusinek H, Chandarana H, Lee VS. Functional MRI of the kidneys. J Magn Reson Imaging 2013;37:282-93. [PMID: 23355431 DOI: 10.1002/jmri.23717] [Cited by in Crossref: 59] [Cited by in F6Publishing: 46] [Article Influence: 7.4] [Reference Citation Analysis]
168 Latus J, Goffin E, Schroeder JA, Fritz P, Ott G, Ulmer C, Steurer W, Kimmel M, Biegger D, Segerer S, Alscher MD, Braun N. Gadolinium deposits could influence the course of encapsulating peritoneal sclerosis. Perit Dial Int 2014;34:561-5. [PMID: 25075001 DOI: 10.3747/pdi.2013.00137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
169 Sammet S, Sammet CL. Implementation of a comprehensive MR safety course for medical students. J Magn Reson Imaging 2015;42:1478-86. [PMID: 26172156 DOI: 10.1002/jmri.24993] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
170 Sena BF, Stern JP, Pandharipande PV, Klemm B, Bulman J, Pedrosa I, Rofsky NM. Screening Patients to Assess Renal Function Before Administering Gadolinium Chelates: Assessment of the Choyke Questionnaire. American Journal of Roentgenology 2010;195:424-8. [DOI: 10.2214/ajr.09.3803] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
171 Chang EH. An Introduction to Contrast-Enhanced Ultrasound for Nephrologists. Nephron 2018;138:176-85. [PMID: 29131073 DOI: 10.1159/000484635] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
172 Li R, Ji Z, Chang CH, Dunphy DR, Cai X, Meng H, Zhang H, Sun B, Wang X, Dong J, Lin S, Wang M, Liao YP, Brinker CJ, Nel A, Xia T. Surface interactions with compartmentalized cellular phosphates explain rare earth oxide nanoparticle hazard and provide opportunities for safer design. ACS Nano 2014;8:1771-83. [PMID: 24417322 DOI: 10.1021/nn406166n] [Cited by in Crossref: 152] [Cited by in F6Publishing: 127] [Article Influence: 21.7] [Reference Citation Analysis]
173 Frenzel T, Apte C, Jost G, Schöckel L, Lohrke J, Pietsch H. Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats. Invest Radiol 2017;52:396-404. [PMID: 28125438 DOI: 10.1097/RLI.0000000000000352] [Cited by in Crossref: 141] [Cited by in F6Publishing: 44] [Article Influence: 47.0] [Reference Citation Analysis]
174 Dillman JR, Davenport MS. Gadolinium retention - 5 years later…. Pediatr Radiol 2020;50:166-7. [PMID: 31975183 DOI: 10.1007/s00247-019-04540-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
175 Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, Jaroudi WA, Meine TJ, White JB, Elliott MD, Kim HW. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009;120:1969-1977. [PMID: 19884472 DOI: 10.1161/circulationaha.109.851352] [Cited by in Crossref: 424] [Cited by in F6Publishing: 131] [Article Influence: 35.3] [Reference Citation Analysis]
176 Liu X, Zhang N, Fan Z, Feng F, Yang Q, Zheng H, Liu P, Li D. Detection of infragenual arterial disease using non-contrast-enhanced MR angiography in patients with diabetes. J Magn Reson Imaging 2014;40:1422-9. [PMID: 24925770 DOI: 10.1002/jmri.24477] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
177 Jenkins W, Perone P, Walker K, Bhagavathula N, Aslam MN, DaSilva M, Dame MK, Varani J. Fibroblast response to lanthanoid metal ion stimulation: potential contribution to fibrotic tissue injury. Biol Trace Elem Res 2011;144:621-35. [PMID: 21484406 DOI: 10.1007/s12011-011-9041-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
178 Tear LR, Maguire ML, Tropiano M, Yao K, Farrer NJ, Faulkner S, Schneider JE. Enhancing 31P NMR relaxation rates with a kinetically inert gadolinium complex. Dalton Trans 2020;49:2989-93. [PMID: 32080690 DOI: 10.1039/c9dt03761f] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
179 Liu Q, Wang X, Xia T. Creative use of analytical techniques and high-throughput technology to facilitate safety assessment of engineered nanomaterials. Anal Bioanal Chem 2018;410:6097-111. [PMID: 30066194 DOI: 10.1007/s00216-018-1289-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
180 McDonald RJ, Levine D, Weinreb J, Kanal E, Davenport MS, Ellis JH, Jacobs PM, Lenkinski RE, Maravilla KR, Prince MR, Rowley HA, Tweedle MF, Kressel HY. Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium Chelates. Radiology 2018;289:517-34. [PMID: 30204075 DOI: 10.1148/radiol.2018181151] [Cited by in Crossref: 121] [Cited by in F6Publishing: 79] [Article Influence: 40.3] [Reference Citation Analysis]
181 Soyer P, Dohan A, Patkar D, Gottschalk A. Observational study on the safety profile of gadoterate meglumine in 35,499 patients: The SECURE study. J Magn Reson Imaging. 2017;45:988-997. [PMID: 27726239 DOI: 10.1002/jmri.25486] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
182 Blumfield E, Swenson DW, Iyer RS, Stanescu AL. Gadolinium-based contrast agents - review of recent literature on magnetic resonance imaging signal intensity changes and tissue deposits, with emphasis on pediatric patients. Pediatr Radiol 2019;49:448-57. [PMID: 30923876 DOI: 10.1007/s00247-018-4304-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
183 Bleavins K, Perone P, Naik M, Rehman M, Aslam MN, Dame MK, Meshinchi S, Bhagavathula N, Varani J. Stimulation of fibroblast proliferation by insoluble gadolinium salts. Biol Trace Elem Res 2012;145:257-67. [PMID: 21882070 DOI: 10.1007/s12011-011-9176-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
184 Chopra T, Kandukurti K, Shah S, Ahmed R, Panesar M. Understanding nephrogenic systemic fibrosis. Int J Nephrol. 2012;2012:912189. [PMID: 23193473 DOI: 10.1155/2012/912189] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
185 Brünjes R, Hofmann T. Anthropogenic gadolinium in freshwater and drinking water systems. Water Res 2020;182:115966. [PMID: 32599421 DOI: 10.1016/j.watres.2020.115966] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
186 Caspani S, Magalhães R, Araújo JP, Sousa CT. Magnetic Nanomaterials as Contrast Agents for MRI. Materials (Basel) 2020;13:E2586. [PMID: 32517085 DOI: 10.3390/ma13112586] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
187 Ravizzini G, Turkbey B, Barrett T, Kobayashi H, Choyke PL. Nanoparticles in sentinel lymph node mapping. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009;1:610-23. [PMID: 20049820 DOI: 10.1002/wnan.48] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
188 Lanzman RS, Kröpil P, Schmitt P, Bi X, Gliem M, Miese FR, Hänggi D, Kamp M, Scherer A, Turowski B, Blondin D. Nonenhanced ECG-gated time-resolved 4D steady-state free precession (SSFP) MR angiography (MRA) for assessment of cerebral collateral flow: comparison with digital subtraction angiography (DSA). Eur Radiol 2011;21:1329-38. [PMID: 21225268 DOI: 10.1007/s00330-010-2051-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
189 Gale EM, Atanasova IP, Blasi F, Ay I, Caravan P. A Manganese Alternative to Gadolinium for MRI Contrast. J Am Chem Soc 2015;137:15548-57. [PMID: 26588204 DOI: 10.1021/jacs.5b10748] [Cited by in Crossref: 143] [Cited by in F6Publishing: 100] [Article Influence: 23.8] [Reference Citation Analysis]
190 Park I, Lupo JM, Nelson SJ. Correlation of Tumor Perfusion Between Carbon-13 Imaging with Hyperpolarized Pyruvate and Dynamic Susceptibility Contrast MRI in Pre-Clinical Model of Glioblastoma. Mol Imaging Biol 2019;21:626-32. [PMID: 30225760 DOI: 10.1007/s11307-018-1275-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
191 Mendichovszky IA, Marks SD, Simcock CM, Olsen OE. Gadolinium and nephrogenic systemic fibrosis: time to tighten practice. Pediatr Radiol. 2008;38:489-496; quiz 602-603. [PMID: 17943276 DOI: 10.1007/s00247-007-0633-8] [Cited by in Crossref: 71] [Cited by in F6Publishing: 51] [Article Influence: 5.1] [Reference Citation Analysis]
192 Hwang R, Mirshafiee V, Zhu Y, Xia T. Current approaches for safer design of engineered nanomaterials. Ecotoxicol Environ Saf 2018;166:294-300. [PMID: 30273853 DOI: 10.1016/j.ecoenv.2018.09.077] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 5.3] [Reference Citation Analysis]
193 Prabhakaran V, Nair VA, Austin BP, La C, Gallagher TA, Wu Y, McLaren DG, Xu G, Turski P, Rowley H. Current status and future perspectives of magnetic resonance high-field imaging: a summary. Neuroimaging Clin N Am 2012;22:373-97, xii. [PMID: 22548938 DOI: 10.1016/j.nic.2012.02.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
194 Zhen Z, Xie J. Development of manganese-based nanoparticles as contrast probes for magnetic resonance imaging. Theranostics 2012;2:45-54. [PMID: 22272218 DOI: 10.7150/thno.3448] [Cited by in Crossref: 88] [Cited by in F6Publishing: 72] [Article Influence: 9.8] [Reference Citation Analysis]
195 Saxena SK, Sharma M, Patel M, Oreopoulos D. Nephrogenic systemic fibrosis: an emerging entity. Int Urol Nephrol 2008;40:715-24. [PMID: 18418727 DOI: 10.1007/s11255-008-9361-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
196 Bhagavathula N, DaSilva M, Aslam MN, Dame MK, Warner RL, Xu Y, Fisher GJ, Johnson KJ, Swartz R, Varani J. Regulation of collagen turnover in human skin fibroblasts exposed to a gadolinium-based contrast agent. Invest Radiol 2009;44:433-9. [PMID: 19561517 DOI: 10.1097/RLI.0b013e3181a4d7e9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
197 Karcaaltincaba M, Oguz B, Haliloglu M. Current status of contrast-induced nephropathy and nephrogenic systemic fibrosis in children. Pediatr Radiol 2009;39 Suppl 3:382-4. [PMID: 19440757 DOI: 10.1007/s00247-009-1236-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
198 Biglands JD, Radjenovic A, Ridgway JP. Cardiovascular magnetic resonance physics for clinicians: Part II. J Cardiovasc Magn Reson. 2012;14:66. [PMID: 22995744 DOI: 10.1186/1532-429x-14-66] [Cited by in Crossref: 51] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
199 Lou M, Chen Z, Wan J, Hu H, Cai X, Shi Z, Sun J. Susceptibility-diffusion mismatch predicts thrombolytic outcomes: a retrospective cohort study. AJNR Am J Neuroradiol. 2014;35:2061-2067. [PMID: 25012670 DOI: 10.3174/ajnr.a4017] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 4.1] [Reference Citation Analysis]
200 Elmholdt TR, Jørgensen B, Ramsing M, Pedersen M, Olesen AB. Two cases of nephrogenic systemic fibrosis after exposure to the macrocyclic compound gadobutrol. NDT Plus 2010;3:285-7. [PMID: 28657062 DOI: 10.1093/ndtplus/sfq028] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
201 Thomsen HS; European Society of Urogenital Radiology (ESUR). ESUR guideline: gadolinium-based contrast media and nephrogenic systemic fibrosis. Eur Radiol 2007;17:2692-6. [PMID: 17977076 DOI: 10.1007/s00330-007-0744-5] [Cited by in Crossref: 117] [Cited by in F6Publishing: 80] [Article Influence: 9.0] [Reference Citation Analysis]
202 Riser BL, Bhagavathula N, Perone P, Garchow K, Xu Y, Fisher GJ, Najmabadi F, Attili D, Varani J. Gadolinium-induced fibrosis is counter-regulated by CCN3 in human dermal fibroblasts: a model for potential treatment of nephrogenic systemic fibrosis. J Cell Commun Signal 2012;6:97-105. [PMID: 22648571 DOI: 10.1007/s12079-012-0164-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
203 Kali A, Cokic I, Tang RL, Yang HJ, Sharif B, Marbán E, Li D, Berman DS, Dharmakumar R. Determination of location, size, and transmurality of chronic myocardial infarction without exogenous contrast media by using cardiac magnetic resonance imaging at 3 T. Circ Cardiovasc Imaging 2014;7:471-81. [PMID: 24682268 DOI: 10.1161/CIRCIMAGING.113.001541] [Cited by in Crossref: 41] [Cited by in F6Publishing: 27] [Article Influence: 5.9] [Reference Citation Analysis]
204 Braun HJ, Gold GE. Advanced MRI of articular cartilage.Imaging Med. 2011;3:541-555. [PMID: 22162977 DOI: 10.2217/iim.11.43] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
205 Chi YH, Hsiao JK, Lin MH, Chang C, Lan CH, Wu HC. Lung Cancer-Targeting Peptides with Multi-subtype Indication for Combinational Drug Delivery and Molecular Imaging. Theranostics 2017;7:1612-32. [PMID: 28529640 DOI: 10.7150/thno.17573] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
206 Mazhar SM, Shiehmorteza M, Kohl CA, Middleton MS, Sirlin CB. Nephrogenic systemic fibrosis in liver disease: a systematic review. J Magn Reson Imaging 2009;30:1313-22. [PMID: 19937937 DOI: 10.1002/jmri.21983] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
207 Platzek I, Sieron D, Wiggermann P, Laniado M. Carotid Artery Stenosis: Comparison of 3D Time-of-Flight MR Angiography and Contrast-Enhanced MR Angiography at 3T. Radiol Res Pract 2014;2014:508715. [PMID: 24778875 DOI: 10.1155/2014/508715] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
208 Ogata H, Kumata-Maeta C, Shishido K, Mizobuchi M, Yamamoto M, Koiwa F, Kinugasa E, Akizawa T. Detection of peripheral artery disease by duplex ultrasonography among hemodialysis patients. Clin J Am Soc Nephrol 2010;5:2199-206. [PMID: 20798256 DOI: 10.2215/CJN.09451209] [Cited by in Crossref: 24] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
209 Chung S, Revia RA, Zhang M. Graphene Quantum Dots and Their Applications in Bioimaging, Biosensing, and Therapy. Adv Mater 2021;33:e1904362. [PMID: 31833101 DOI: 10.1002/adma.201904362] [Cited by in Crossref: 64] [Cited by in F6Publishing: 25] [Article Influence: 32.0] [Reference Citation Analysis]
210 Qin L, Sun Z, Cheng K, Liu S, Pang J, Xia L, Chen W, Cheng Z, Chen J. Zwitterionic Manganese and Gadolinium Metal–Organic Frameworks as Efficient Contrast Agents for in Vivo Magnetic Resonance Imaging. ACS Appl Mater Interfaces 2017;9:41378-86. [DOI: 10.1021/acsami.7b09608] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 7.8] [Reference Citation Analysis]
211 Reilly RF. Risk for nephrogenic systemic fibrosis with gadoteridol (ProHance) in patients who are on long-term hemodialysis. Clin J Am Soc Nephrol 2008;3:747-51. [PMID: 18287249 DOI: 10.2215/CJN.05721207] [Cited by in Crossref: 85] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
212 Ponrartana S, Moore MM, Chan SS, Victoria T, Dillman JR, Chavhan GB. Safety issues related to intravenous contrast agent use in magnetic resonance imaging. Pediatr Radiol 2021;51:736-47. [PMID: 33871726 DOI: 10.1007/s00247-020-04896-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
213 Merrill LJ, Gurnett CA, Siegel M, Sonavane S, Dobbs MB. Vascular abnormalities correlate with decreased soft tissue volumes in idiopathic clubfoot. Clin Orthop Relat Res. 2011;469:1442-1449. [PMID: 21042891 DOI: 10.1007/s11999-010-1657-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
214 Liu P, Welch BG, Li Y, Gu H, King D, Yang Y, Pinho M, Lu H. Multiparametric imaging of brain hemodynamics and function using gas-inhalation MRI. Neuroimage 2017;146:715-23. [PMID: 27693197 DOI: 10.1016/j.neuroimage.2016.09.063] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
215 Smorodinsky E, Ansdell DS, Foster ZW, Mazhar SM, Cruite I, Wolfson T, Sugay SB, Iussich G, Shiehmorteza M, Kono Y, Kuo A, Sirlin CB. Risk of nephrogenic systemic fibrosis is low in patients with chronic liver disease exposed to gadolinium-based contrast agents. J Magn Reson Imaging 2015;41:1259-67. [PMID: 24811860 DOI: 10.1002/jmri.24650] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
216 Mirshafiee V, Jiang W, Sun B, Wang X, Xia T. Facilitating Translational Nanomedicine via Predictive Safety Assessment. Mol Ther 2017;25:1522-30. [PMID: 28412168 DOI: 10.1016/j.ymthe.2017.03.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
217 Zhang N, Zou L, Huang Y, Liu D, Tang Y, Fan Z, Chen H, Liu X. Non-Contrast Enhanced MR Angiography (NCE-MRA) of the Calf: A Direct Comparison between Flow-Sensitive Dephasing (FSD) Prepared Steady-State Free Precession (SSFP) and Quiescent-Interval Single-Shot (QISS) in Patients with Diabetes. PLoS One 2015;10:e0128786. [PMID: 26035645 DOI: 10.1371/journal.pone.0128786] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
218 Wentland AL, Artz NS, Fain SB, Grist TM, Djamali A, Sadowski EA. MR measures of renal perfusion, oxygen bioavailability and total renal blood flow in a porcine model: noninvasive regional assessment of renal function. Nephrol Dial Transplant 2012;27:128-35. [PMID: 21622986 DOI: 10.1093/ndt/gfr199] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
219 Rajca A, Wang Y, Boska M, Paletta JT, Olankitwanit A, Swanson MA, Mitchell DG, Eaton SS, Eaton GR, Rajca S. Organic radical contrast agents for magnetic resonance imaging. J Am Chem Soc 2012;134:15724-7. [PMID: 22974177 DOI: 10.1021/ja3079829] [Cited by in Crossref: 121] [Cited by in F6Publishing: 86] [Article Influence: 13.4] [Reference Citation Analysis]
220 Turgutalp K, Kiykim A, Özhan O, Helvaci I, Ozcan T, Yildiz A. Comparison of diagnostic accuracy of Doppler USG and contrast-enhanced magnetic resonance angiography and selective renal arteriography in patients with atherosclerotic renal artery stenosis. Med Sci Monit 2013;19:475-82. [PMID: 23778330 DOI: 10.12659/MSM.889035] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 1.4] [Reference Citation Analysis]
221 Hamamoto K, Matsuura K, Chiba E, Okochi T, Tanno K, Tanaka O. Feasibility of Non-contrast-enhanced MR Angiography Using the Time-SLIP Technique for the Assessment of Pulmonary Arteriovenous Malformation. Magn Reson Med Sci 2016;15:253-65. [PMID: 26841853 DOI: 10.2463/mrms.mp.2015-0069] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
222 Nidhin M, Vedhanayagam M, Sangeetha S, Kiran MS, Nazeer SS, Jayasree RS, Sreeram KJ, Nair BU. Fluorescent nanonetworks: a novel bioalley for collagen scaffolds and tissue engineering. Sci Rep 2014;4:5968. [PMID: 25095810 DOI: 10.1038/srep05968] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
223 Cukur T, Lustig M, Nishimura DG. Improving non-contrast-enhanced steady-state free precession angiography with compressed sensing. Magn Reson Med 2009;61:1122-31. [PMID: 19230013 DOI: 10.1002/mrm.21907] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
224 Karabulut N. Gadolinium deposition in the brain: another concern regarding gadolinium-based contrast agents. Diagn Interv Radiol 2015;21:269-70. [PMID: 26133320 DOI: 10.5152/dir.2015.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
225 Sieber MA, Lengsfeld P, Frenzel T, Golfier S, Schmitt-Willich H, Siegmund F, Walter J, Weinmann HJ, Pietsch H. Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions. Eur Radiol 2008;18:2164-73. [PMID: 18545998 DOI: 10.1007/s00330-008-0977-y] [Cited by in Crossref: 153] [Cited by in F6Publishing: 127] [Article Influence: 11.8] [Reference Citation Analysis]
226 Pietsch H, Lengsfeld P, Jost G, Frenzel T, Hütter J, Sieber MA. Long-term retention of gadolinium in the skin of rodents following the administration of gadolinium-based contrast agents. Eur Radiol 2009;19:1417-24. [PMID: 19169690 DOI: 10.1007/s00330-008-1259-4] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 4.3] [Reference Citation Analysis]
227 Turyanskaya A, Rauwolf M, Pichler V, Simon R, Burghammer M, Fox OJL, Sawhney K, Hofstaetter JG, Roschger A, Roschger P, Wobrauschek P, Streli C. Detection and imaging of gadolinium accumulation in human bone tissue by micro- and submicro-XRF. Sci Rep 2020;10:6301. [PMID: 32286449 DOI: 10.1038/s41598-020-63325-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
228 Bhooshan N, Giger M, Medved M, Li H, Wood A, Yuan Y, Lan L, Marquez A, Karczmar G, Newstead G. Potential of computer-aided diagnosis of high spectral and spatial resolution (HiSS) MRI in the classification of breast lesions. J Magn Reson Imaging 2014;39:59-67. [PMID: 24023011 DOI: 10.1002/jmri.24145] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
229 Zhang JL, Morrell G, Rusinek H, Sigmund EE, Chandarana H, Lerman LO, Prasad PV, Niles D, Artz N, Fain S. New magnetic resonance imaging methods in nephrology. Kidney Int. 2014;85:768-778. [PMID: 24067433 DOI: 10.1038/ki.2013.361] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 7.4] [Reference Citation Analysis]
230 Liszewski MC, Görkem S, Sodhi KS, Lee EY. Lung magnetic resonance imaging for pneumonia in children. Pediatr Radiol 2017;47:1420-30. [PMID: 29043418 DOI: 10.1007/s00247-017-3865-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 6.8] [Reference Citation Analysis]
231 Rutherford E, Talle MA, Mangion K, Bell E, Rauhalammi SM, Roditi G, McComb C, Radjenovic A, Welsh P, Woodward R, Struthers AD, Jardine AG, Patel RK, Berry C, Mark PB. Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping. Kidney Int. 2016;90:845-852. [PMID: 27503805 DOI: 10.1016/j.kint.2016.06.014] [Cited by in Crossref: 65] [Cited by in F6Publishing: 47] [Article Influence: 13.0] [Reference Citation Analysis]